腹膜后恶性肿瘤切除术后，5年生存率为14．5％。
The 5-year survival rate for malignant retroperitoneal tumors is 14.5%.
结论原发性腹膜后恶性肿瘤术前灌注是安全、有效的治疗方法，有助于外科手术治疗。
Conclusion Preoperative transcatheter arterial infusion is a safe, effective therapy for the treatment of PRMT, it is helpful to the surgery.
本文报告了17例经二维及双功能多普勒超声诊断的腹膜后肿物，其中良性肿物3例(17.6%)，恶性肿瘤13例(76.5%)，有恶性倾向的肿瘤1例。
This article reports 17 cases with retroperitoneal masses diagnosed by 2-d imaging and duplex Doppler, including 3 benign masses (17.6%), 13 malignant tumor, (76.5%) and one malignant potential.
恶性肿瘤常伴腹水，盆腔或腹膜后淋巴结肿大，大网膜增厚呈饼状，腹腔种植转移和肝脏转移。
Malignant carcinomas usually presented with ascites, pelvic and post-peritoneum enlarged lymph nodes, greater omentum like biscuits, peritoneum implanting and liver metastases.
观察希罗达同步三维适形放疗治疗恶性肿瘤腹膜后淋巴结转移的近期疗效及毒副反应。
The objoctive of this study was to observe the efficacy and side effect of concurrent Xeloda and three-dimensional conformal radiotherapy(3DCRT)for retroperitoneal lymph node metastases.
观察希罗达同步三维适形放疗治疗恶性肿瘤腹膜后淋巴结转移的近期疗效及毒副反应。
The objoctive of this study was to observe the efficacy and side effect of concurrent Xeloda and three-dimensional conformal radiotherapy(3DCRT)for retroperitoneal lymph node metastases.
应用推荐